Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection.
Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis.
Characterization of a eukaryotic-like protein kinase, DspB, with an atypical catalytic loop motif from Myxococcus xanthus.
Role of Sortilin in Models of Autoimmune Neuroinflammation.
Specific immune complexes augment in vitro acetylcholine receptor-specific T-cell proliferation.
Behçet's syndrome: a critical digest of the 2012-2013 literature.
Higher Blood Pressure Partially Links Greater Adiposity to Reduced Brain White Matter Integrity.
Vaccine-associated inflammatory diseases of the central nervous system: from signals to causation.
Novel somatic single nucleotide variants within the RNA binding protein hnRNP A1 in multiple sclerosis patients.
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Neurologic diseases of the central nervous system with pathophysiologically relevant autoantibodies - Perspectives for immunoadsorption.
Enhancing our understanding of white matter changes in early multiple sclerosis.
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Pregnancy Data in a Turkish Multiple Sclerosis Population.
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Acute disseminated encephalomyelitis: case report and brief review.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
Immune Modulatory Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells Through a Trophoblast-like Stage.
Pages
« first
‹ previous
…
664
665
666
667
668
669
670
671
672
…
next ›
last »